Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Generic Clearance for Quick Turnaround Testing of Communication Effectiveness, 35392-35393 [2019-15623]
Download as PDF
<![CDATA[
35392
Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION: Title IV–E
of the Social Security Act (the Act) was
amended by Public Law 115–123, which
included the Family First Prevention
Services Act (FFPSA). The FFPSA
authorized new optional title IV–E
funding for time-limited (one year)
prevention services for mental health/
substance abuse and in-home parent
skill-based programs for: (1) A child
who is a candidate for foster care (as
defined in section 475(13) of the Act),
(2) pregnant/parenting foster youth, and
(3) the parents/kin caregivers of those
children and youth (sections 471(e),
474(a)(6), and 475(13) of the Act). Title
IV–E prevention services must be rated
as promising, supported, or wellsupported in accordance with HHS
criteria and be approved by HHS
(section 471(e)(4)(C) of the Act) as part
of the Title IV–E Prevention Services
Clearinghouse (section 476(d)(2) of the
Act). A state or tribal title IV–E agency
electing to participate in the program
must submit a five-year title IV–E
prevention program plan that meets the
statutory requirements. (See Program
Instructions ACYF–CB–PI–18–09 and
ACYF–CB–PI–18–10 for more
information.)
The FFPSA also amended Section
474(a)(7) of the Act to reimburse state
and tribal IV–E agencies for a portion of
the costs of operating kinship navigator
programs that meet certain criteria. To
qualify for funding under the title IV–
E Kinship Navigator program, the
program must meet the requirements of
a kinship navigator program described
in section 427(a)(1) of the Act. The
kinship navigator program must also
meet practice criteria of promising,
supported, or well-supported in
accordance with HHS criteria and be
approved by HHS (section 471(e)(4)(C)
of the Act). To begin participation in the
title IV–E Kinship Navigator Program, a
title IV–E agency must submit an
attachment to its title IV–E plan that
specifies the Kinship Navigator model it
has chosen to implement, the date on
which the provision of program services
began or will begin, and that provides
an assurance that the model meets the
requirements of section 427(a)(1) of the
Act as well as a brief narrative
describing how the program will be
operated. (Please see Program
Instruction ACYF–CB–PI–18–11 for
additional information.)
Respondents: State and tribal title IV–
E agencies.
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
Instrument
Title IV–E prevention services plan .................................................................
Attachment to Title IV–E plan for Kinship navigator program .........................
Estimated Total Annual Burden
Hours: 195.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: Title IV–E of the Social
Security Act as amended by Public Law (Pub.
L.) 115–123 enacted February 9, 2018.
jspears on DSK30JT082PROD with NOTICES
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2019–15603 Filed 7–22–19; 8:45 am]
BILLING CODE 4184–25–P
VerDate Sep<11>2014
16:43 Jul 22, 2019
Jkt 247001
30
45
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–N–0430]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Generic Clearance
for Quick Turnaround Testing of
Communication Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
Fax written comments on the
collection of information by August 22,
2019.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer,
Fax: 202–395–7285, or emailed to
DATES:
Frm 00024
Fmt 4703
1
1
Average
burden
hours per
response
Annual
burden
hours
5
1
150
45
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910-New and
title ‘‘Generic Clearance for Quick
Turnaround Testing of Communication
Effectiveness.’’ Also include the FDA
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT: Ila
S. Mizrachi, Office of Operations, Food
and Drug Administration, Three White
Flint North, 10A–12M, 11601
Landsdown St., North Bethesda, MD
20852, 301–796–7726, PRAStaff@
fda.hhs.gov.
In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
SUPPLEMENTARY INFORMATION:
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995
(PRA).
SUMMARY:
PO 00000
Number of
responses per
respondent
Sfmt 4703
Generic Clearance for Quick
Turnaround Testing of Communication
Effectiveness
OMB Control Number 0910–NEW
This notice announces the FDA
information collection request to OMB
for approval of a generic clearance that
will allow FDA to use quick turnaround
surveys, focus groups, and in-depth
interviews collected from consumers
and other stakeholders to communicate
FDA issues of immediate and important
public health significance. For example,
E:\FR\FM\23JYN1.SGM
23JYN1
35393
Federal Register / Vol. 84, No. 141 / Tuesday, July 23, 2019 / Notices
these methods of communication might
be used when there is a foodborne
illness outbreak, food recall, or other
situation requiring expedited FDA food,
dietary supplement, cosmetics, or
animal food or feed communications. So
that FDA may better protect the public
health, the Agency needs quick
turnaround information to help ensure
its messaging has reached the target
audience, has been effective, and, if
needed, to update its communications
during these events.
FDA will only submit individual
collections for approval under this
generic clearance if they meet the
following conditions:
• The collections are voluntary;
• The collections are low burden for
participants (based on considerations of
total burden hours, total number of
participants, or burden hours per
participant) and are low cost for both
the participants and the Federal
Government;
• The collections are
noncontroversial;
• Personally identifiable information
(PII) is collected only to the extent
necessary 1 and is not retained;
• Information gathered will not be
used for the purpose of substantially
informing influential policy decisions; 2
and
• Information gathered will yield
qualitative findings; the collections will
not be designed or used as though the
results are generalizable to the
population of study.
If these conditions are not met, FDA
will submit an information collection
request to OMB for approval through the
normal PRA process.
To obtain approval for an individual
collection that meets the conditions of
this generic clearance, an abbreviated
supporting statement will be submitted
to OMB along with supporting
documentation (e.g., a copy of the
survey, focus group moderator guide, or
in-depth interviewing guide).
Individual collections will also
undergo review by FDA senior
leadership in the Center for Food Safety
and Applied Nutrition, PRA specialists,
and an institutional review board.
Respondents to this collection of
information include a wide range of
consumers and other FDA stakeholders
such as producers and manufacturers
who are regulated under FDA-regulated
food and cosmetic products, dietary
supplements, and animal food and feed.
In the Federal Register of April 2,
2019 (84 FR 12617), FDA published a
60-day notice requesting public
comment on the proposed collection of
information. FDA received no
comments.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Survey type
Total annual
responses
Average burden hours
per response
Total hours
In-depth Interviews, Cognitive Interviews Screener
In-depth Interviews, Cognitive Interviews ................
In-depth Interviews Screener ...................................
In-depth Interviews ...................................................
Survey Cognitive Interviews Screener .....................
Survey Cognitive Interviews ....................................
Pretest survey screener ...........................................
Pretest survey ..........................................................
Self-Administered Surveys—Study Screener ..........
Self-Administered Surveys .......................................
Focus Group/Small Group, Cognitive Groups
Screener.
Focus Group/Small Group, Cognitive Groups .........
Focus Group/Small Group Participant Screening ...
Focus Group/Small Group Discussion ....................
45
9
900
180
45
9
750
150
75,000
15,000
180
1
1
1
1
1
1
1
1
1
1
1
45
9
900
180
45
9
750
150
75,000
15,000
180
0.083 (5 minutes) ......
1 ................................
0.083 (5 minutes) ......
1 ................................
0.083 (5 minutes) ......
1 ................................
0.083 (5 minutes) ......
0.25 (15 minutes) ......
0.083 (5 minutes) ......
0.25 (15 minutes) ......
0.083 (5 minutes) ......
4
9
75
180
4
9
62.25
38
6,225
3,750
15
60
720
240
1
1
1
60
720
240
1.5 (90 minutes) ........
0.083 (5 minutes) ......
1.5 (90 minutes) ........
90
60
360
Total ..................................................................
........................
........................
........................
....................................
10,881.25
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
This is a new collection of
information whose total estimated
annual burden is 10,881.25 hours.
Current estimates are based on both
historical numbers of participants from
past projects as well as estimates for
projects to be conducted in the next 3
years. The number of participants to be
included in each new individual survey
will vary, depending on the nature of
the compliance efforts and the target
audience.
jspears on DSK30JT082PROD with NOTICES
Number of
responses per
respondent
Dated: July 16, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019–15623 Filed 7–22–19; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0065]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Registration of
Food Facilities
AGENCY:
Food and Drug Administration,
HHS.
1 For example, collections that collect PII to
provide remuneration for participants of focus
groups, in-depth interviews, and cognitive
laboratory studies will be submitted under this
request. All privacy act requirements will be met.
VerDate Sep<11>2014
16:43 Jul 22, 2019
Jkt 247001
2 As defined in OMB and Agency Information
Quality Guidelines, ‘‘influential’’ means that ‘‘an
agency can reasonably determine that
dissemination of the information will have or does
have a clear and substantial impact on important
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
public policies or important private sector
decisions.’’
E:\FR\FM\23JYN1.SGM
23JYN1
]]>Agencies
[Federal Register Volume 84, Number 141 (Tuesday, July 23, 2019)]
[Notices]
[Pages 35392-35393]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-15623]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2019-N-0430]
Agency Information Collection Activities; Submission for Office
of Management and Budget Review; Comment Request; Generic Clearance for
Quick Turnaround Testing of Communication Effectiveness
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that a
proposed collection of information has been submitted to the Office of
Management and Budget (OMB) for review and clearance under the
Paperwork Reduction Act of 1995 (PRA).
DATES: Fax written comments on the collection of information by August
22, 2019.
ADDRESSES: To ensure that comments on the information collection are
received, OMB recommends that written comments be faxed to the Office
of Information and Regulatory Affairs, OMB, Attn: FDA Desk Officer,
Fax: 202-395-7285, or emailed to [email protected]. All
comments should be identified with the OMB control number 0910-New and
title ``Generic Clearance for Quick Turnaround Testing of Communication
Effectiveness.'' Also include the FDA docket number found in brackets
in the heading of this document.
FOR FURTHER INFORMATION CONTACT: Ila S. Mizrachi, Office of Operations,
Food and Drug Administration, Three White Flint North, 10A-12M, 11601
Landsdown St., North Bethesda, MD 20852, 301-796-7726,
[email protected].
SUPPLEMENTARY INFORMATION: In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for
review and clearance.
Generic Clearance for Quick Turnaround Testing of Communication
Effectiveness
OMB Control Number 0910-NEW
This notice announces the FDA information collection request to OMB
for approval of a generic clearance that will allow FDA to use quick
turnaround surveys, focus groups, and in-depth interviews collected
from consumers and other stakeholders to communicate FDA issues of
immediate and important public health significance. For example,
[[Page 35393]]
these methods of communication might be used when there is a foodborne
illness outbreak, food recall, or other situation requiring expedited
FDA food, dietary supplement, cosmetics, or animal food or feed
communications. So that FDA may better protect the public health, the
Agency needs quick turnaround information to help ensure its messaging
has reached the target audience, has been effective, and, if needed, to
update its communications during these events.
FDA will only submit individual collections for approval under this
generic clearance if they meet the following conditions:
The collections are voluntary;
The collections are low burden for participants (based on
considerations of total burden hours, total number of participants, or
burden hours per participant) and are low cost for both the
participants and the Federal Government;
The collections are noncontroversial;
Personally identifiable information (PII) is collected
only to the extent necessary \1\ and is not retained;
---------------------------------------------------------------------------
\1\ For example, collections that collect PII to provide
remuneration for participants of focus groups, in-depth interviews,
and cognitive laboratory studies will be submitted under this
request. All privacy act requirements will be met.
---------------------------------------------------------------------------
Information gathered will not be used for the purpose of
substantially informing influential policy decisions; \2\ and
---------------------------------------------------------------------------
\2\ As defined in OMB and Agency Information Quality Guidelines,
``influential'' means that ``an agency can reasonably determine that
dissemination of the information will have or does have a clear and
substantial impact on important public policies or important private
sector decisions.''
---------------------------------------------------------------------------
Information gathered will yield qualitative findings; the
collections will not be designed or used as though the results are
generalizable to the population of study.
If these conditions are not met, FDA will submit an information
collection request to OMB for approval through the normal PRA process.
To obtain approval for an individual collection that meets the
conditions of this generic clearance, an abbreviated supporting
statement will be submitted to OMB along with supporting documentation
(e.g., a copy of the survey, focus group moderator guide, or in-depth
interviewing guide).
Individual collections will also undergo review by FDA senior
leadership in the Center for Food Safety and Applied Nutrition, PRA
specialists, and an institutional review board.
Respondents to this collection of information include a wide range
of consumers and other FDA stakeholders such as producers and
manufacturers who are regulated under FDA-regulated food and cosmetic
products, dietary supplements, and animal food and feed.
In the Federal Register of April 2, 2019 (84 FR 12617), FDA
published a 60-day notice requesting public comment on the proposed
collection of information. FDA received no comments.
FDA estimates the burden of this collection of information as
follows:
Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of
Survey type Number of responses per Total annual Average burden hours per response Total hours
respondents respondent responses
--------------------------------------------------------------------------------------------------------------------------------------------------------
In-depth Interviews, Cognitive Interviews 45 1 45 0.083 (5 minutes)......................... 4
Screener.
In-depth Interviews, Cognitive Interviews... 9 1 9 1......................................... 9
In-depth Interviews Screener................ 900 1 900 0.083 (5 minutes)......................... 75
In-depth Interviews......................... 180 1 180 1......................................... 180
Survey Cognitive Interviews Screener........ 45 1 45 0.083 (5 minutes)......................... 4
Survey Cognitive Interviews................. 9 1 9 1......................................... 9
Pretest survey screener..................... 750 1 750 0.083 (5 minutes)......................... 62.25
Pretest survey.............................. 150 1 150 0.25 (15 minutes)......................... 38
Self-Administered Surveys--Study Screener... 75,000 1 75,000 0.083 (5 minutes)......................... 6,225
Self-Administered Surveys................... 15,000 1 15,000 0.25 (15 minutes)......................... 3,750
Focus Group/Small Group, Cognitive Groups 180 1 180 0.083 (5 minutes)......................... 15
Screener.
Focus Group/Small Group, Cognitive Groups... 60 1 60 1.5 (90 minutes).......................... 90
Focus Group/Small Group Participant 720 1 720 0.083 (5 minutes)......................... 60
Screening.
Focus Group/Small Group Discussion.......... 240 1 240 1.5 (90 minutes).......................... 360
-----------------------------------------------------------------------------------------------------------
Total................................... .............. .............. .............. .......................................... 10,881.25
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
This is a new collection of information whose total estimated
annual burden is 10,881.25 hours. Current estimates are based on both
historical numbers of participants from past projects as well as
estimates for projects to be conducted in the next 3 years. The number
of participants to be included in each new individual survey will vary,
depending on the nature of the compliance efforts and the target
audience.
Dated: July 16, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-15623 Filed 7-22-19; 8:45 am]
BILLING CODE 4164-01-P
